These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 12188389

  • 1. Risk of breast cancer in post-menopausal women using hormone replacement therapy.
    Ratanawichitrasin A, Reansuwan W, Ratanawichitrasin S, Bhodhisuwan K, Kongpatanakul S.
    J Med Assoc Thai; 2002 May; 85(5):583-9. PubMed ID: 12188389
    [Abstract] [Full Text] [Related]

  • 2. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD.
    Am J Epidemiol; 2007 May 15; 165(10):1187-98. PubMed ID: 17337757
    [Abstract] [Full Text] [Related]

  • 3. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
    Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R.
    Cancer Epidemiol Biomarkers Prev; 2003 Nov 15; 12(11 Pt 1):1175-81. PubMed ID: 14652277
    [Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL, Ingvar C, Bladström A.
    Cancer; 2003 Mar 15; 97(6):1387-92. PubMed ID: 12627501
    [Abstract] [Full Text] [Related]

  • 5. Variability of breast cancer risk in observational studies of hormone replacement therapy: a meta-regression analysis.
    Garbe E, Levesque L, Suissa S.
    Maturitas; 2004 Mar 15; 47(3):175-83. PubMed ID: 15036487
    [Abstract] [Full Text] [Related]

  • 6. Hormone replacement treatment and breast cancer risk: an age-specific analysis.
    Tavani A, Braga C, La Vecchia C, Negri E, Franceschi S.
    Cancer Epidemiol Biomarkers Prev; 1997 Jan 15; 6(1):11-4. PubMed ID: 8993791
    [Abstract] [Full Text] [Related]

  • 7. A case-control study of hormone replacement therapy after primary surgical breast cancer treatment.
    Ursic-Vrscaj M, Bebar S.
    Eur J Surg Oncol; 1999 Apr 15; 25(2):146-51. PubMed ID: 10218456
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for breast cancer in Turkish women: a hospital-based case-control study.
    Beji NK, Reis N.
    Eur J Cancer Care (Engl); 2007 Mar 15; 16(2):178-84. PubMed ID: 17371428
    [Abstract] [Full Text] [Related]

  • 9. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk.
    Mills PK, Riordan DG, Cress RD, Goldsmith DF.
    Cancer Detect Prev; 2005 Mar 15; 29(2):124-32. PubMed ID: 15829372
    [Abstract] [Full Text] [Related]

  • 10. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL.
    Cancer Epidemiol Biomarkers Prev; 2008 May 15; 17(5):1082-7. PubMed ID: 18483329
    [Abstract] [Full Text] [Related]

  • 11. Menstrual factors in relation to breast cancer risk.
    Titus-Ernstoff L, Longnecker MP, Newcomb PA, Dain B, Greenberg ER, Mittendorf R, Stampfer M, Willett W.
    Cancer Epidemiol Biomarkers Prev; 1998 Sep 15; 7(9):783-9. PubMed ID: 9752986
    [Abstract] [Full Text] [Related]

  • 12. An analysis of the effect of selection bias on the association of hormone replacement therapy and breast cancer risk.
    Csizmadi I, Friedenreich CM, Bryant HE, Courneya KS.
    Chronic Dis Can; 2005 Sep 15; 26(2-3):73-9. PubMed ID: 16251013
    [Abstract] [Full Text] [Related]

  • 13. [Replacement therapy in menopause and risk for breast tumors].
    Franceschi S.
    Ann Ist Super Sanita; 1997 Sep 15; 33(2):207-11. PubMed ID: 9470242
    [Abstract] [Full Text] [Related]

  • 14. Use of hormone replacement therapy among cardiac patients at a Canadian academic centre.
    Wise MR, Stewart DE, Liu P, Abramson BL.
    CMAJ; 1999 Jul 13; 161(1):33-6. PubMed ID: 10420861
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA, Borofsky ND, Massardo S, Orentreich N.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec 13; 11(12):1566-73. PubMed ID: 12496045
    [Abstract] [Full Text] [Related]

  • 16. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
    Tzingounis V, Cardamakis E, Ginopoulos P, Argiropoulos G.
    Anticancer Res; 1996 Dec 13; 16(6C):3997-4000. PubMed ID: 9042326
    [Abstract] [Full Text] [Related]

  • 17. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 18. Association of paternal age at birth and the risk of breast cancer in offspring: a case control study.
    Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Yoo KY, Kang D.
    BMC Cancer; 2005 Oct 31; 5():143. PubMed ID: 16259637
    [Abstract] [Full Text] [Related]

  • 19. Reproductive factors and breast cancer risk among older women.
    Shantakumar S, Terry MB, Teitelbaum SL, Britton JA, Millikan RC, Moorman PG, Neugut AI, Gammon MD.
    Breast Cancer Res Treat; 2007 May 31; 102(3):365-74. PubMed ID: 17033925
    [Abstract] [Full Text] [Related]

  • 20. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L, Dell'Aniello S, Assouline S, Suissa S.
    BJOG; 2008 Jan 31; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.